Leo Wealth LLC lowered its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 5.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,212 shares of the company’s stock after selling 302 shares during the quarter. Leo Wealth LLC’s holdings in Colgate-Palmolive were worth $541,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CL. Fisher Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 1,010.7% during the fourth quarter. Fisher Asset Management LLC now owns 3,210 shares of the company’s stock valued at $256,000 after acquiring an additional 2,921 shares during the last quarter. Park Avenue Securities LLC raised its holdings in shares of Colgate-Palmolive by 20.5% during the first quarter. Park Avenue Securities LLC now owns 7,368 shares of the company’s stock valued at $663,000 after acquiring an additional 1,252 shares during the last quarter. RFG Advisory LLC raised its holdings in shares of Colgate-Palmolive by 6.4% during the first quarter. RFG Advisory LLC now owns 5,299 shares of the company’s stock valued at $477,000 after acquiring an additional 317 shares during the last quarter. Global Assets Advisory LLC acquired a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $3,505,000. Finally, DGS Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 110.1% during the first quarter. DGS Capital Management LLC now owns 5,510 shares of the company’s stock valued at $496,000 after acquiring an additional 2,888 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Insider Activity
In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Stock Report on CL
Colgate-Palmolive Trading Up 0.3 %
Shares of NYSE CL opened at $99.68 on Wednesday. Colgate-Palmolive has a twelve month low of $71.46 and a twelve month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The stock has a fifty day simple moving average of $103.38 and a 200-day simple moving average of $97.83. The stock has a market capitalization of $81.78 billion, a PE ratio of 31.54, a PEG ratio of 3.54 and a beta of 0.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. During the same period in the previous year, the firm posted $0.77 earnings per share. The company’s revenue was up 4.9% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.01%. Colgate-Palmolive’s payout ratio is presently 63.29%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- 3 Small Caps With Big Return Potential
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.